Vranic et al. [6] found that 33.3% of all SpCC expressed PD-L1 in cancer cells above the 1% threshold, 3 of them exhibiting diffuse PD-L1 expression in cancer cells (50–100% cancer cell positive). This evidence concerns the gene CD274 and cancer.